Merck & Co., Inc.'s longtime leader of global clinical development, chief medical officer Roy Baynes, is leaving the company to work with his former boss Roger Perlmutter at the biotech start-up Eikon Therapeutics, Inc..
Baynes will be succeeded by another executive with a long tenure at Merck. Senior VP-global clinical development Eliav Barr, who...